table of content
1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Global Pediatric Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pediatric Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pediatric Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Pediatric Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pediatric Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pediatric Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.4 Pediatric Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pediatric Drugs and Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pediatric Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pediatric Drugs and Vaccines Market Dynamics
1.5.1 Pediatric Drugs and Vaccines Industry Trends
1.5.2 Pediatric Drugs and Vaccines Market Drivers
1.5.3 Pediatric Drugs and Vaccines Market Challenges
1.5.4 Pediatric Drugs and Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pediatric Drugs and Vaccines Market Segment by Type
2.1.1 Diphtheria
2.1.2 Influenza
2.1.3 Hepatitis
2.1.4 Pneumococcal Diseases
2.1.5 Meningococcal Diseases
2.1.6 Mumps
2.1.7 Others
2.2 Global Pediatric Drugs and Vaccines Market Size by Type
2.2.1 Global Pediatric Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pediatric Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pediatric Drugs and Vaccines Market Size by Type
2.3.1 United States Pediatric Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pediatric Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pediatric Drugs and Vaccines Market Segment by Application
3.1.1 Newborn
3.1.2 Infant
3.1.3 Child
3.2 Global Pediatric Drugs and Vaccines Market Size by Application
3.2.1 Global Pediatric Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pediatric Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pediatric Drugs and Vaccines Market Size by Application
3.3.1 United States Pediatric Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pediatric Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pediatric Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pediatric Drugs and Vaccines Competitor Landscape by Company
4.1 Global Pediatric Drugs and Vaccines Market Size by Company
4.1.1 Top Global Pediatric Drugs and Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Pediatric Drugs and Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Pediatric Drugs and Vaccines Price by Manufacturer (2017-2022)
4.2 Global Pediatric Drugs and Vaccines Concentration Ratio (CR)
4.2.1 Pediatric Drugs and Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pediatric Drugs and Vaccines in 2021
4.2.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Pediatric Drugs and Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pediatric Drugs and Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pediatric Drugs and Vaccines Market Size by Company
4.5.1 Top Pediatric Drugs and Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pediatric Drugs and Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pediatric Drugs and Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Pediatric Drugs and Vaccines Market Size by Region
5.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pediatric Drugs and Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Pediatric Drugs and Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pediatric Drugs and Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Pediatric Drugs and Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Pediatric Drugs and Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co., Inc. (USA)
7.1.1 Merck & Co., Inc. (USA) Corporation Information
7.1.2 Merck & Co., Inc. (USA) Description and Business Overview
7.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.1.5 Merck & Co., Inc. (USA) Recent Development
7.2 Abbott Laboratories (USA)
7.2.1 Abbott Laboratories (USA) Corporation Information
7.2.2 Abbott Laboratories (USA) Description and Business Overview
7.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
7.2.5 Abbott Laboratories (USA) Recent Development
7.3 Amgen, Inc. (USA)
7.3.1 Amgen, Inc. (USA) Corporation Information
7.3.2 Amgen, Inc. (USA) Description and Business Overview
7.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.3.5 Amgen, Inc. (USA) Recent Development
7.4 Eli Lilly and Company (USA)
7.4.1 Eli Lilly and Company (USA) Corporation Information
7.4.2 Eli Lilly and Company (USA) Description and Business Overview
7.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
7.4.5 Eli Lilly and Company (USA) Recent Development
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
7.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
7.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
7.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
7.6 Genentech, Inc. (USA)
7.6.1 Genentech, Inc. (USA) Corporation Information
7.6.2 Genentech, Inc. (USA) Description and Business Overview
7.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.6.5 Genentech, Inc. (USA) Recent Development
7.7 GlaxoSmithKline plc. (UK)
7.7.1 GlaxoSmithKline plc. (UK) Corporation Information
7.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview
7.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
7.7.5 GlaxoSmithKline plc. (UK) Recent Development
7.8 Janssen Biologics B.V. (USA)
7.8.1 Janssen Biologics B.V. (USA) Corporation Information
7.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
7.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
7.8.5 Janssen Biologics B.V. (USA) Recent Development
7.9 Actelion Pharmaceuticals
7.9.1 Actelion Pharmaceuticals Corporation Information
7.9.2 Actelion Pharmaceuticals Description and Business Overview
7.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
7.9.5 Actelion Pharmaceuticals Recent Development
7.10 AstraZeneca Plc. (UK)
7.10.1 AstraZeneca Plc. (UK) Corporation Information
7.10.2 AstraZeneca Plc. (UK) Description and Business Overview
7.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
7.10.5 AstraZeneca Plc. (UK) Recent Development
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
7.11.2 Boehringer Ingelheim GmbH (Germany) Description and Business Overview
7.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
7.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
7.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview
7.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Bristol-Myers Squibb Company (USA) Products Offered
7.12.5 Bristol-Myers Squibb Company (USA) Recent Development
7.13 Allergan, Inc. (USA)
7.13.1 Allergan, Inc. (USA) Corporation Information
7.13.2 Allergan, Inc. (USA) Description and Business Overview
7.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Allergan, Inc. (USA) Products Offered
7.13.5 Allergan, Inc. (USA) Recent Development
7.14 Novartis AG (Switzerland)
7.14.1 Novartis AG (Switzerland) Corporation Information
7.14.2 Novartis AG (Switzerland) Description and Business Overview
7.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Novartis AG (Switzerland) Products Offered
7.14.5 Novartis AG (Switzerland) Recent Development
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Novo Nordisk A/S (Denmark) Corporation Information
7.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview
7.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Novo Nordisk A/S (Denmark) Products Offered
7.15.5 Novo Nordisk A/S (Denmark) Recent Development
7.16 Pfizer, Inc. (USA)
7.16.1 Pfizer, Inc. (USA) Corporation Information
7.16.2 Pfizer, Inc. (USA) Description and Business Overview
7.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Pfizer, Inc. (USA) Products Offered
7.16.5 Pfizer, Inc. (USA) Recent Development
7.17 Sanofi S.A (France)
7.17.1 Sanofi S.A (France) Corporation Information
7.17.2 Sanofi S.A (France) Description and Business Overview
7.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Sanofi S.A (France) Products Offered
7.17.5 Sanofi S.A (France) Recent Development
7.18 Shionogi Inc. (USA)
7.18.1 Shionogi Inc. (USA) Corporation Information
7.18.2 Shionogi Inc. (USA) Description and Business Overview
7.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Shionogi Inc. (USA) Products Offered
7.18.5 Shionogi Inc. (USA) Recent Development
7.19 Takeda
7.19.1 Takeda Corporation Information
7.19.2 Takeda Description and Business Overview
7.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Takeda Products Offered
7.19.5 Takeda Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pediatric Drugs and Vaccines Industry Chain Analysis
8.2 Pediatric Drugs and Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pediatric Drugs and Vaccines Distributors
8.3 Pediatric Drugs and Vaccines Production Mode & Process
8.4 Pediatric Drugs and Vaccines Sales and Marketing
8.4.1 Pediatric Drugs and Vaccines Sales Channels
8.4.2 Pediatric Drugs and Vaccines Distributors
8.5 Pediatric Drugs and Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
